HRT Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
HRT Financial's AMPH Position: Q2 2026 in Review
HRT Financial increased its Amphastar Pharmaceuticals (AMPH) stake by 590% in Q2 2026, buying an estimated $6.68M and bringing the position to 387,530 shares worth $7.82M. The position accounts for 0.01% of the portfolio, ranked #896.
HRT Financial first reported a position in AMPH in Q2 2020 and has held it in 14 quarters since. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- HRT Financial held 387,530 shares of Amphastar Pharmaceuticals worth $7.82M as of Q2 2026.
- HRT Financial bought 331,349 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $6.68M.
- Amphastar Pharmaceuticals made up 0.01% of HRT Financial's portfolio in Q2 2026, its #896 holding.
- HRT Financial first reported a position in Amphastar Pharmaceuticals in Q2 2020 and has held it in 14 quarters since.
- 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.